The Biology and Lab Reports of Specific Antibody Deficiency

While many immune disorders are diagnosed by looking at the quantity of your antibodies, Specific Antibody Deficiency (SAD) is diagnosed by looking at their function. In SAD, the “bricks and mortar” of your immune system look perfectly normal on standard blood tests, but they fail to work when faced with a specific type of bacterial challenge ^[1].

A Functional Defect, Not a Shortage

It is common for patients with SAD to have normal results on most initial immune screenings. This is because SAD is biologically different from other common deficiencies:

• Vs. CVID: In Common Variable Immunodeficiency (CVID), your body has a physical shortage of antibodies; total IgG is low, and often IgA or IgM are low as well ^[2]. In SAD, these levels are completely normal ^[3].
• Vs. IgG Subclass Deficiency: This occurs when one of the four specific types of IgG (like IgG1 or IgG2) is physically low ^[4]. In classic SAD, all IgG subclasses are within the normal range ^[3].
• The SAD Difference: Your body has enough antibodies, and they respond perfectly to protein-based vaccines (like tetanus). The defect is purely functional: your immune system does not effectively respond to the polysaccharide (sugar) coating on certain bacteria ^[5].

The Vaccine Challenge Test

The vaccine challenge test is central to diagnosing SAD, though a diagnosis combines this with a compatible clinical history of recurrent infections. Doctors measure your titers—the amount of specific antibodies in your blood—before and after a vaccine.

1. The Baseline Draw: Blood is drawn to see your current immunity to various strains (serotypes) of Streptococcus pneumoniae ^[6].
2. The Challenge: You receive the PPSV23 (Pneumovax 23) vaccine. Unlike some other vaccines, this is a pure polysaccharide vaccine, meaning it contains only the sugary coatings of 23 different bacterial strains ^[7].
3. The Post-Vaccine Draw: Generally 4 to 8 weeks later, your blood is drawn again to see if your immune system learned how to fight those strains ^[8].

Crucial Detail: It is highly preferable to use the same laboratory for both blood draws ^[6]. Different labs use different testing panels and reference ranges, making cross-lab comparisons more difficult for your specialist to interpret accurately ^[1].

Navigating the “Prevnar” Nuance

Most children (and many adults) have already received a conjugate vaccine like PCV13, PCV15, PCV20, or PCV21 (Capvaxive). These vaccines attach the bacterial sugars to a protein, which makes them easier for the immune system to see ^[9].

Because of this, a person might show great immunity to the strains in the conjugate vaccine but still fail to respond to the unique strains found only in the pure polysaccharide PPSV23 vaccine ^[10]. When an immunologist reviews your report, they often focus on the “unprimed” strains—the ones your body had to learn to fight on its own, without the protein ^[11]. PPSV23 testing after prior conjugate vaccination should be presented as an individualized specialist decision, not a standard challenge that every patient must undergo.

Understanding Severity Cutoffs

A value of 1.3 μg/mL is a commonly used convention for some PPSV23 assays to indicate a protective titer ^[12]. Some older clinical frameworks categorized severity using this cutoff: for example, 7–10 protective serotypes as mild, 3–6 as moderate, and ≤2 as severe ^[12].

However, patients should not classify themselves using this single cutoff. Severity categories depend heavily on age, baseline titers, prior conjugate vaccination, and sometimes fold change. For example, older children and adults are generally expected to mount a response to about 70% of tested serotypes, while children ages 2–5 may need about 50% ^[13][1]. Since PCV20 leaves only a few unique serotypes to test, simple “out of 23” counts can be misleading ^[11]. Your immunologist will interpret the actual assay.

Your Lab Report Completeness Checklist

When you receive your lab results, discuss these details with your specialist:

• [ ] Baseline Titers: Do you have the “pre-vaccine” numbers for each serotype?
• [ ] Post-Vaccine Titers: Do you have the “post-vaccine” numbers?
• [ ] The Timing Window: Was the second draw done roughly 4 to 8 weeks after the shot? ^[8]
• [ ] Lab Consistency: Were the results processed by the same laboratory? ^[6]
• [ ] Vaccine History: Does your doctor know exactly which conjugate vaccine (PCV13, 15, 20, or 21) you had in the past? ^[11]
• [ ] Protein Check: Does the report also show a normal response to a protein vaccine like Tetanus or Diphtheria? ^[3]